Company intelligence / Profile preview

Royal DSM

Heerlen, Limburg, Netherlands

Ownership: Private
Employees: ~21000
Development stage: Other

Overview

Before its merger into dsm-firmenich, Royal DSM was a global leader in the development and commercial distribution of nutritional ingredients, probiotics, enzymes, and specialty chemicals, with a strong focus on health, nutrition, bioscience, and materials applications[1][3][4].

Therapeutic areas: Metabolic DisordersOther
Modalities: Small moleculeBiologicEnzymeProbioticProteinPeptides
Industry: Non-Drug Biotech

Partnerships

Various business, government, and academic partners worldwide[1]Numerous biotech and pharma ingredient and technology partnerships (e.g., probiotics development, enzyme innovation)

Beyond the preview

Go deeper on Royal DSM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal DSM.

Explore the full profile